BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2002
View Archived Issues
Telomerase inhibitors under study at Pharmacia
Read More
Novel 5-HT6 ligands for depression, anxiety, cognitive disorders, etc., claimed in recent patent
Read More
AstraZeneca team identifies kappa opioid agonists
Read More
TLK-286 enters two new combination trials
Read More
Amended phase II protocol for FM-VP4
Read More
Argenta Discovery and Amedis extend collaboration
Read More
Provectus acquires company recently split from Photogen
Read More
Milnacipran improves FMS pain and fatigue in preliminary analysis
Read More
Phase III Ampligen trial in CFS completes enrollment
Read More
Paladin returns Canadian DepoCyt rights to SkyePharma
Read More
Pharmexa and Lundbeck Alzheimer's collaboration achieves proof of concept in animals
Read More
Minimal toxicity reported for SGN-30 in Hodgkin's disease and lymphoma
Read More
Potential use of MLN-518 in AML and high-risk MDS
Read More
Significant improvement reported on eculizumab in patients with paroxysmal nocturnal hemoglobinuria
Read More
Reduced liver iron content in thalassemic patients treated with ICL-670
Read More
Comparison of warfarin and idraparinux sodium in deep vein thrombosis
Read More
New cephem antibiotics discovered jointly by Fujisawa and Wakunaga
Read More
Series of 5-HT1A antagonists in early development at Wyeth
Read More
KuDOS and Maybridge claim isoquinoline-based PARP inhibitors
Read More
New tyrosine kinase inhibitors and their use in proliferative disorders
Read More
Veronate granted fast track status
Read More
Helix BioPharma completes acquisition of minority interest in Sensium
Read More
Medicure enters research collaboration with university group for NHE inhibitors
Read More
GSK identifies novel 5-HT7 receptor antagonist with good pharmacokinetic properties
Read More
Fully human MAb to human VEGFR-3 designed at ImClone Systems
Read More
Pharmacological profile of VX-944, an IMPDH inhibitor, characterized at ASH meeting
Read More